StockData
Fortrea Holdings Inc. logo

Fortrea Holdings Inc. (FTRE) stock

FTRENasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 4/3067% above fair value
$20.15−0.35 (-1.71%)

Close on Nov 19, 2026Market cap $1.94BP/E –Yield –

Fortrea net income

Net income is the profit left for shareholders after every expense, interest and tax.

Fortrea's net income for the twelve months ending Sep 30, 2026 was -$68.70M. For fiscal 2025 it was -$986.20M. The highest annual figure on record is $186.20M in fiscal 2022.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$986.20M–
FY2024Dec 31, 2024-$328.50M–
FY2023Dec 31, 2023-$25.20M-113.5%
FY2022Dec 31, 2022$186.20M+90.0%
FY2021Dec 31, 2021$98.00M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$600.00K–
Q2 FY2026Jun 30, 2026-$13.20M–
Q1 FY2026Mar 31, 2026-$23.60M–
Q4 FY2025Dec 31, 2025-$32.50M–
Q3 FY2025Sep 30, 2025-$15.90M–
Q2 FY2025Jun 30, 2025-$374.90M–
Q1 FY2025Mar 31, 2025-$562.90M–
Q4 FY2024Dec 31, 2024-$61.20M–
Q3 FY2024Sep 30, 2024-$27.90M–
Q2 FY2024Jun 30, 2024-$138.40M-549.4%
Q1 FY2024Mar 31, 2024-$101.00M-908.0%
Q4 FY2023Dec 31, 2023-$54.50M-304.1%
Q3 FY2023Sep 30, 2023-$14.00M-123.1%
Q2 FY2023Jun 30, 2023$30.80M-53.6%
Q1 FY2023Mar 31, 2023$12.50M-61.5%
Q4 FY2022Dec 31, 2022$26.70M–
Q3 FY2022Sep 30, 2022$60.60M–
Q2 FY2022Jun 30, 2022$66.40M–
Q1 FY2022Mar 31, 2022$32.50M–

More Fortrea figures

See a number that looks wrong?